Research Progress and Perspectives of Antibody-drug Conjugates Targeting Trophoblast Cell Surface Antigen-2 in Advanced Non-small Cell Lung Cancer.

Non-small cell lung cancer (NSCLC) remains a significant global health burden, and there is an urgent need for new treatment options. Trophoblast cell surface antigen-2 (TROP-2), a target closely associated with NSCLC prognosis, has become a research hotspot in recent years. Notably, TROP-2-targeted...

Full description

Bibliographic Details

Published in:	Chinese Journal of Lung Cancer Vol. 27; no. 10; pp. 763 - 777
Main Authors:	Jingyan XU, Jiaqi LIU, Shiqi MEI, Qing ZHOU
Format:	pictorial tables/charts Journal Article
Published:	Chinese Journal of Lung Cancer Oct2024
Online Access:	View this record in EBSCOhost